TubianaM., MalaiseE.P.: Growth rate and cell kinetics in human tumors: some prognostic and therapeutic implications. SymingtonT., CarterA.L. (eds.): Scientific Foundations of Oncology, Chicago, Year Book Medical, 126, 1976.
2.
PaulsonD.F., RobertsonJ.E., DaubertL.M., WaltherP.J.: Radical prostatectomy in stage A prostatic adenocarcinoma. J. Urol., 140; 535 (1988).
3.
DenisL., NewlingD., SmithP., SylvesterR., MalherC., De PauwM., Members of the EORTC GU Group. Antwerp, Belgium: Orchidectomy versus total androgen blockade: a phase III EORTC 30853 study. A.U.A.1988.
4.
LabrieF., DupontA., BelangerA., GiguerM., LacoursiereY., EmondJ., MonfetteG., BergeronV.: Combination therapy with flutamide and castration (LHRH agonist or orchidectomy) in advanced prostate cancer: a marked improvement in response and survival. J. Steroid Biochem., 23; 833–844 (1985).
5.
CrawfordE.D., FooteE.J.: Total androgen suppression: Are there any advantages? The use of combined therapy in the treatment of advanced prostate adenocarcinoma. Seminars Urol., 6; 291–302 (1988).
